Full Text View
Tabular View
No Study Results Posted
Related Studies
Ethiopia Malaria Therapeutic Efficacy Study
This study has been completed.
Study NCT01052584   Information provided by Centers for Disease Control and Prevention

First Received on January 17, 2010.   Last Updated on November 17, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Malaria
More general conditions related to this trial
Parasitic Diseases
Protozoan Infections
Interventions listed in this trial
Chloroquine- P. vivax
Artemether-Lumefantrine: P. vivax
Additional drug interventions recognized in this trial
Artemether
Artemether-lumefantrine combination
Artemisinins
Chloroquine
Chloroquine diphosphate
Lumefantrine
More general drug interventions related to this trial
Amebicides
Analgesics
Analgesics, Non-Narcotic
Anthelmintics
Anti-Infective Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antifungal Agents
Antimalarials
Antinematodal Agents
Antiparasitic Agents
Antiplatyhelmintic Agents
Antiprotozoal Agents
Antirheumatic Agents
Central Nervous System Agents
Coccidiostats
Filaricides
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Schistosomicides
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Centers for Disease Control and Prevention
United States Agency for International Development (USAID)
Columbia University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services